BOOSTING THE INNATE IMMUNE SYSTEM

 

Even with current vaccines, anti-virals and antibiotics
significant unmet needs remain to better prevent and treat  respiratory infections

 

Pulmotect technology has demonstrated activity and completed Phase I clinical trials to address these unmet needs

 

IMMUNOCOMPROMISED PATIENTS

Forecast sales for the immuno-stimulants market are estimated to reach $17.6 billion

~ The Cancer Market Outlook to 2013:
Competitive landscape, pipeline analysis
and growth opportunities

EPIDEMIC

More than 2 billion people worldwide
could be impacted by a pandemic. 160 million Americans will need to be vaccinated.

~TIME

 CDC Declares 2015 Flu Epidemic

 

EMERGING PATHOGENS

Despite remarkable advances in medical research and treatments during the 20th century, infectious diseases remain among the leading causes of death worldwide.

~ National Institute of
Allergy and Infectious Disease